Related Experiment Video
Updated: Apr 3, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare system
Paul E Milligan1, Mary C Bocox2, Elizabeth Pratt2
1Paul E. Milligan, Pharm.D., is Medication Safety Pharmacist, BJC HealthCare, St. Louis, MO, and Washington University School of Medicine, St. Louis. Mary C. Bocox, M.P.H., M.Ed., is Clinical Epidemiologist, BJC HealthCare. Elizabeth Pratt, D.N.P., RN, ACNS-BC, is Research Scientist, Nurse Specialist, Barnes-Jewish Hospital, St. Louis. Christine M. Hoehner, Ph.D., M.S.P.H., is Epidemiologist Supervisor, Quality Analytics, BJC HealthCare. John E. Krettek, M.D., Ph.D., is Vice President, Clinical Improvement, BJC HealthCare. Wm. Claiborne Dunagan, M.D., M.S., is Professor of Medicine, Washington University School of Medicine, and Senior Vice President and Chief Clinical Officer, BJC HealthCare. paul.milligan@bjc.org.
Purpose:
Substantial reductions in inpatient episodes of severe hypoglycemia achieved by a large healthcare system through enhanced use of technology and sustained quality-improvement initiatives are described.
Summary:
After internal data collection and analysis revealed that severe hypoglycemia accounted for 75% of all systematically monitored adverse drug events in its hospital network, St. Louis-based BJC HealthCare designed and executed a multifaceted approach to reducing hypoglycemia events. Initiated by a pharmacist-led task force, the project entailed (1) automated event detection and creation of dashboards for comparing hypoglycemia rates among at-risk patients at 11 BJC facilities, (2) implementation of evidence-based and internal best practices in use at BJC's top-performing hospitals, (3) development of an online "Hypoglycemic Event Analysis Tool" (HEAT) to support event investigation and collection of data on causative factors, and (4) the assembly of targeted interventions at a "Hypoglycemia Facility Strategy Tracking" (H-FaST) intranet site. As a result of the launch of the HEAT and H-FaST tools and associated provider education activities, the systemwide rate of hypoglycemia events in the specified at-risk patient population declined from 6.45 per 1000 patient-days during a preimplementation baseline period (July-December 2009) to 1.32 per 1000 patient-days during a designated postimplementation period (January-June 2014), an 80% overall reduction in hypoglycemia (p < 0.01); reductions in severe hypoglycemia events ranging from 70% to 100% were observed at all 11 hospitals.
Conclusion:
A multifaceted, evidence-based, data-driven approach enabled a large healthcare system to markedly reduce the frequency of severe hypoglycemia events.
Related Concept Videos
Hypoglycemia and Glucagon
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

